Shapiro CL

No ORCID on file · 1 paper in corpus

2015

Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer.

Molecular and cellular endocrinology ·doi:10.1016/j.mce.2014.12.028

PurposeChemotherapy induced ovarian failure (CIOF) results in rapid bone loss. Receptor Activator of Nuclear Factor Kappa-B (RANK)-RANK ligand (RANK-L) signaling balances bone resorption and formation. Osteoprotegerin (OPG) acts as a decoy …